Ekocorp

Ekocorp EBITDA per Share

The EBITDA per Share of Ekocorp (EKOCORP.NL) as of Oct 23, 2026 is -0.60 NGN. In the previous year, EBITDA per Share was -0.48 NGN — a change of 24.75% (lower).

EBITDA per Share

-0.60NGN

YoY

24.75%

Last updated:

EBITDA per Share of Ekocorp is 2020 -0.60 NGN. EBITDA per Share of Ekocorp was 2019 -0.48 NGN. It decreases by 24.75% lower compared to the previous year.

The Ekocorp EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2015
0.40 NGN
Jan 1, 2016
0.23 NGN
Jan 1, 2017
0.06 NGN
Jan 1, 2018
-0.39 NGN
Jan 1, 2019
-0.48 NGN
Jan 1, 2020
-0.60 NGN
The Ekocorp EBITDA per Share history
YEAREBITDA per ShareYoY
-0.60NGN+24.75%
-0.48NGN+24.11%
-0.39NGN-757.32%
0.06NGN-74.43%
0.23NGN-41.92%
0.40NGN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

EBITDA per Share of Ekocorp is -0.60 NGN in 2020.

EBITDA per Share of Ekocorp changed from -0.48 NGN to -0.60 NGN, representing a 24.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Ekocorp since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ekocorp

All Key Metrics — Ekocorp